{"id":"butinoline","rwe":[],"tags":[{"label":"butinoline","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"budifin","offLabel":[],"synonyms":["butinoline","budifin"],"timeline":[],"brandName":"Budifin","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"butinoline","explanation":"Imagine your body's cells have locks on them, and Budifin is a key that fits into those locks. When it binds to the lock, it triggers a series of events that help to treat a particular condition. This process is called a molecular interaction, and it's a fundamental way that many medications work.","oneSentence":"Budifin is believed to work by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Budifin's mechanism of action is likely to involve the modulation of a specific protein or receptor, leading to changes in downstream signaling pathways and ultimately resulting in its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/448","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BUTINOLINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:06:46.816905","biosimilars":[],"competitors":[],"genericName":"butinoline","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"007038","UNII":"G216926E9T","CHEBI":"CHEBI:135213","INN_ID":"1631","UMLSCUI":"C0772190","ChEMBL_ID":"CHEMBL1442660","PUBCHEM_CID":"68943","SNOMEDCT_US":"703409004"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Budifin (Butinoline) is a small molecule drug in the butinoline class, but specific details about its development, approval status, and commercial availability are not provided. As a pharma professional, it is essential to note that the target, indications, pharmacokinetics, and safety profile of Budifin are unknown. Further research is necessary to understand its mechanism of action, efficacy, and potential side effects. The commercial status of Budifin, including patent status and generic availability, is also unclear. A comprehensive review of the available literature is required to determine the current status of this compound.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}